Stella Pharma: Extraordinary Report
Stella Pharma: Securities Report - 17th Period (April 1, 2023 - March 31, 2024).
Stella Pharma: Confirmatory letter.
Stella Pharma: Financial results briefing materials for the fiscal year ending March 2024
Stella Pharma: Supplemental Financial Results for the Fiscal Year Ending March 2024
Stella Pharma: Summary of financial results for the fiscal year ending March 2024 [Japanese GAAP] (unconsolidated)
Stellar Pharma: Quarterly Report - 17th Quarter 3rd Quarter (2023/10/01 - 2023/12/31)
Stellar Pharma: Confirmation Letter
Stella Pharma: Supplemental financial results for the 3rd quarter of the fiscal year ending March 31, 2024
Stella Pharma: Notice regarding revisions to earnings forecasts
Stella Pharma: Summary of financial results for the 3rd quarter of the fiscal year ending March 31, 2024 [Japanese GAAP] (unconsolidated)
Stella Pharma: 2nd quarter financial results briefing materials for the fiscal year ending March 31, 2024
Stella Pharma: (Corrections and Numerical Data Corrections) Partial Corrections to the “Summary of Financial Results for the 2nd Quarter Ending March 31, 2024 [Japanese GAAP] (unconsolidated)”
Stella Pharma: Confirmation letter
Stella Pharma: Quarterly Report - 17th Second Quarter (2023/07/01 - 2023/09/30)
Stella Pharma: Supplementary financial results for the 2nd quarter of the fiscal year ending March 31, 2024
Stella Pharma: Summary of financial results for the 2nd quarter of the fiscal year ending March 31, 2024 [Japanese GAAP] (unconsolidated)
Stella Pharma: Confirmation letter
Stella Pharma: Quarterly Report - 1st Quarter 17th (2023/04/01 - 2023/06/30)
Stella Pharma: Supplementary materials for financial results for the first quarter of the fiscal year ending March 31, 2024
No Data